Establishment Labs Holdings Inc. (NASDAQ: ESTA) has appointed healthcare executive Taylor Harris to its board of directors, adding a seasoned... Read More
The post Establishment Labs Appoints Taylor Harris to Board of Directors appeared first on citybiz.
Kailera Therapeutics has appointed Kathleen Tregoning as chief corporate affairs officer, expanding its executive leadership team as the clinical-stage biotechnology... Read More
The post Kailera Therapeutics Appoints Kathleen Tregoning Chief Corporate Affairs Officer appeared first on citybiz.
Xilio Therapeutics Inc. (Nasdaq: XLO) has appointed biopharmaceutical legal executive Ben Harshbarger as chief legal officer, adding experienced leadership as... Read More
The post Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer appeared first on citybiz.
NovaBridge Biosciences (Nasdaq: NBP) has appointed physician-executive Dr. Srishti Gupta as chief executive officer and a member of its board... Read More
The post NovaBridge Biosciences Names Dr. Srishti Gupta CEO to Lead Clinical Development Strategy appeared first on citybiz.
San Francisco-based Assort Health has raised $120 million in a Series C round led by Menlo Ventures, a deal that... Read More
The post Joe Montana Joins $120M Series C for Voice AI Venture Assort Health appeared first on citybiz.
David Lazerson is Co-founder and CEO of Briya, a healthcare technology company supporting vital medical and biopharma research and innovation... Read More
The post Q&A with David Lazerson, Co-Founder & CEO of Briya appeared first on citybiz.
DirectTrust has announced new and returning members of its Board of Directors and the Electronic Healthcare Network Accreditation Commission (EHNAC), expanding... Read More
The post DirectTrust Appoints New Board Members and EHNAC Commissioners appeared first on citybiz.
Envision Pharma Group has promoted Jennifer Lospinoso to President of Riparian, the company’s pricing, access and value optimization business, as it... Read More
The post Envision Pharma Group Promotes Jennifer Lospinoso to Lead Riparian Business Unit appeared first on citybiz.
Arrakis Therapeutics has appointed biotech executive Mark DeLong as chief executive officer, effective June 29, 2026, as the company prepares... Read More
The post Arrakis Therapeutics Names Mark DeLong CEO Ahead of Clinical-Stage Transition appeared first on citybiz.
Cambridge, Mass.-based Oblenio Bio has raised an oversubscribed $62 million Series B funding round led by Pfizer Ventures, as the... Read More
The post Oblenio Bio Raises $62M to Advance New Therapies for Autoimmune Diseases appeared first on citybiz.
Azara Healthcare has appointed healthcare technology executive Mary Lantin as president and chief executive officer, effective June 15, 2026, as... Read More
The post Azara Healthcare Appoints Mary Lantin President and CEO to Drive Next Growth Phase appeared first on citybiz.
Candel Therapeutics Inc. (Nasdaq: CADL) has appointed oncology commercial executive Mark Sims as Chief Commercial Officer as the clinical-stage biotechnology... Read More
The post Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer Ahead of Planned BLA Filing appeared first on citybiz.
Delivering complex therapeutic molecules safely and efficiently remains one of the biggest challenges in the development of next-generation medicines. While... Read More
The post Hatch BioFund Invests in Optimeos Life Sciences to Advance Nanoparticle Drug Delivery Platform appeared first on citybiz.
Paris- and Boston-based Tissium has secured about €60 million, or $68.1 million, to push its tissue reconstruction platform deeper into... Read More
The post Tissium Secures $68M for US Launch of Sutureless Nerve Repair System appeared first on citybiz.
Takeda (NYSE: TAK; TSE: 4502) has completed its planned leadership succession with the appointment of Julie Kim as Representative Director,... Read More
The post Takeda Appoints Julie Kim President and CEO, Completes Leadership Transition appeared first on citybiz.
Novavax Inc. (NASDAQ: NVAX) is facing renewed pressure from its largest shareholder, Shah Capital, after the biotech company secured approval for all... Read More
The post Novavax Draws Fresh Criticism From Largest Shareholder Shah Capital Following Annual Meeting appeared first on citybiz.
Anodyne Nanotech has closed a $12.6 million Series A financing to advance its lead obesity treatment candidate, a once-weekly GLP-1... Read More
The post Anodyne Nanotech Raises $12.6 Million Series A to Advance Weekly GLP-1 Patch appeared first on citybiz.
Austin, Texas-based Ollin Biosciences has closed an oversubscribed $330 million Series B funding round co-led by Palo Alto, Calif.-based TCGX... Read More
The post Ollin Biosciences Raises $330M to Advance Late-Stage Eye Disease Drug appeared first on citybiz.
BioIVT, a provider of biospecimen solutions and research services for the life sciences industry, has appointed Sean Downing, Ph.D., to... Read More
The post BioIVT Appoints Sean Downing to Scientific Advisory Board appeared first on citybiz.
Strata Critical Medical has completed the acquisition of Heart and Lung Transplant National Recovery Program (HLT-NRP), a U.S. provider of... Read More
The post Strata Acquires HLT-NRP to Expand National Organ Recovery Platform appeared first on citybiz.
New York-based Cadence, a clinical AI company that helps manage chronic care for older adults, has closed a $100 million... Read More
The post Cadence Raises $100M Series C Led by Spark Capital to Automate Chronic Care appeared first on citybiz.
Alpha Cognition Inc. (Nasdaq: ACOG) has elected Dr. Robert Wills as chairman of its board of directors, succeeding Len Mertz,... Read More
The post Alpha Cognition Elects Biopharma Veteran Dr. Robert Wills as Board Chairman appeared first on citybiz.
Ladder Health, a virtual-first pediatric developmental care company, has raised $7 million in an oversubscribed seed financing round to expand... Read More
The post Ladder Health Raises $7 Million Seed Round to Expand Pediatric Developmental Care Platform appeared first on citybiz.
Tria Federal has appointed Rajiv Uppal, former chief information officer of both the Centers for Medicare & Medicaid Services and... Read More
The post Tria Federal Appoints Former CMS and IRS CIO Rajiv Uppal to Advisory Board appeared first on citybiz.
Castle Biosciences, Inc. (Nasdaq: CSTL) announced that Chief Financial Officer Frank Stokes has been recognized as a 2026 CFO Awards... Read More
The post Castle Biosciences CFO Frank Stokes Named Houston Business Journal CFO Awards Honoree appeared first on citybiz.
Sangamo Therapeutics Inc. (NASDAQ: SGMO), a clinical-stage biotechnology company focused on genomic medicine, has filed for Chapter 11 bankruptcy protection... Read More
The post Sangamo Therapeutics Files for Chapter 11 Bankruptcy Protection appeared first on citybiz.
San Francisco-based Nura Bio, a clinical-stage biopharmaceutical company developing neuroprotective small molecule therapies, has announced the completion of a $73.8... Read More
The post Nura Bio Secures $74M Series B to Advance ALS Drug appeared first on citybiz.
John Bellinger, co-founder and chief executive officer of Food Safety Net Services (FSNS) and a board member of Certified Group,... Read More
The post USDA Appoints Certified Group Board Member John Bellinger as Advisor on New World Screwworm Preparedness appeared first on citybiz.
Paris- and Boston-based Bionyra Pharma, has announced the company’s launch with a $165 million oversubscribed Series A funding round co-led... Read More
The post Bionyra Pharma Launches With $165M Series A to Advance Inflammatory Disease Treatments appeared first on citybiz.
Prolium Bioscience, Inc. (Prolium), a clinical stage biotechnology company, today announced that the first patient has been dosed in a... Read More
The post Prolium Bioscience Doses First Patient in Global Phase 1/2 Systemic Sclerosis Study of PRO-203 appeared first on citybiz.
VSee Health Inc. (NASDAQ: VSEE) reported strong operational and financial momentum following the sale of its VSee Lab business, highlighting... Read More
The post VSee Health Reports Revenue Growth and Lower Costs Following VSee Lab Divestiture appeared first on citybiz.
PrescriberPoint has named healthcare executive and physician leader Steven Strongwater, M.D., as Chief Medical Officer, creating a new leadership position... Read More
The post PrescriberPoint Appoints Dr. Steven Strongwater as Chief Medical Officer appeared first on citybiz.
DermDox Group has acquired Modern Aesthetics Plastic Surgery, expanding its capabilities in aesthetic medicine and cosmetic surgery as the physician-led... Read More
The post DermDox Group Acquires Modern Aesthetics Plastic Surgery, Expanding Mid-Atlantic Platform appeared first on citybiz.
eGenesis has strengthened its executive leadership team with the appointment of Glenn S. Vraniak as chief financial officer and the... Read More
The post eGenesis Names Glenn Vraniak CFO, Promotes Jennifer Bergheiser to Chief Commercial Officer appeared first on citybiz.
Biond Biologics has appointed Giovanni Selvaggi, M.D., as Chief Medical Officer, adding a veteran oncology drug development executive as the... Read More
The post Biond Biologics Names Giovanni Selvaggi Chief Medical Officer to Advance Immunotherapy Pipeline appeared first on citybiz.
San Diego, Calif.-based cAMPfield Therapeutics has announced its launch with a $180 million Series A funding round, as the clinical-stage... Read More
The post cAMPfield Therapeutics Launches With $180M Series A appeared first on citybiz.
KROMATID has appointed Matthew Hemstreet as chief executive officer, succeeding interim CEO Terry Opgenorth as the company looks to expand... Read More
The post Matthew Hemstreet Named CEO of KROMATID as Company Targets Growth in Cell and Gene Therapy Market appeared first on citybiz.
Premier Biotech, a provider of drug and alcohol testing solutions backed by Align Capital Partners (ACP), has acquired NexScreen and... Read More
The post Premier Biotech Expands Drug Testing Platform With NexScreen and TransMed Acquisitions appeared first on citybiz.
Pfizer Inc. (NYSE: PFE) announced that Chief Financial Officer Dave Denton will step down from his role and leave the... Read More
The post Pfizer Names Cecile Guegan Interim CFO Following Dave Denton’s Departure appeared first on citybiz.
Connie Health has acquired and integrated Clearlink’s Medicare business while leveraging a recently completed $40 million Series B financing to... Read More
The post Connie Health Acquires Clearlink Medicare Business and Expands Growth Strategy With $40 Million Series B appeared first on citybiz.
VERAXA Biotech has reported new in vitro proof-of-concept data supporting its BiTAC-ADC technology platform, a next-generation approach designed to improve... Read More
The post VERAXA Biotech Reports Early Validation of BiTAC-ADC Cancer Therapy Platform appeared first on citybiz.
Portal Biotechnologies has closed an oversubscribed $9 million financing round led by NFX, as the cell engineering company expands commercial... Read More
The post Portal Biotechnologies Raises $9 Million to Scale Cell Engineering Platform appeared first on citybiz.
EBI, a developer of bone growth stimulation technologies and a portfolio company of Avista Healthcare Partners, has acquired Xstim, the... Read More
The post EBI Acquires Xstim to Expand Bone Growth Stimulation Portfolio appeared first on citybiz.
Charlottesville, Va.–based Icarus Medical, which develops orthopedic bracing technology, has closed an oversubscribed $7.2 million Series A funding round. Major... Read More
The post Medtech Firm Icarus Medical Secures $7.2M Series A From Riptide Ventures, Others appeared first on citybiz.
Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on developing therapies for genetically driven neuromuscular diseases, announced it has... Read More
The post Dyne Therapeutics Expands Hercules Capital Debt Facility to Up to $400 Million appeared first on citybiz.
Compliancy Group, a provider of healthcare compliance management solutions, announced the acquisition of Healthicity, a healthcare compliance and auditing software... Read More
The post Compliancy Group Acquires Healthicity, Creating Unified Platform for Healthcare Compliance and Auditing appeared first on citybiz.
Belmont Medical Technologies, a provider of fluid-resuscitation and patient-temperature management solutions, has acquired Arcos, Inc., a Missouri City, Texas-based developer... Read More
The post Belmont Medical Technologies Acquires Arcos to Strengthen Trauma and Burn Care Capabilities appeared first on citybiz.
National Cancer Center (NCC) has appointed Allison Betof-Warner, M.D., Ph.D., and Rizwan Romee, M.D., to its Scientific Advisory Board, adding... Read More
The post National Cancer Center Appoints Stanford and Harvard Researchers to Scientific Advisory Board appeared first on citybiz.
Triveni Bio, a clinical-stage biotechnology company developing novel antibody treatments for immunological and inflammatory disorders, has closed a $65 million... Read More
The post Triveni Bio Raises $65M Series C Co-Led by Ascenta, Henderson Investors appeared first on citybiz.
Acumen Pharmaceuticals has selected two development candidates for its Enhanced Brain Delivery (EBD) program, advancing a new generation of Alzheimer’s... Read More
The post Acumen Selects Two Enhanced Brain Delivery Candidates for Alzheimer’s appeared first on citybiz.
embecta Corp. (Nasdaq: EMBC) has appointed pharmaceutical industry executive Nimish Muzumdar as Senior Vice President and President, North America, strengthening... Read More
The post embecta Appoints Nimish Muzumdar as North America President to Drive Growth Strategy appeared first on citybiz.
Syremis Therapeutics has appointed Aaron Koenig, M.D., as Chief Medical Officer, adding an experienced psychiatrist and drug development executive as... Read More
The post Syremis Therapeutics Names Neuropsychiatry Veteran Dr. Aaron Koenig Chief Medical Officer appeared first on citybiz.
Latus Bio has appointed biotechnology industry veteran Bethany Mancilla as Chief Business Officer, strengthening its leadership team as the company... Read More
The post Latus Bio Names Bethany Mancilla Chief Business Officer as Clinical Plans Advance appeared first on citybiz.
Rejoni, Inc., a clinical-stage medical technology company focused on uterine health, has secured $25 million in financing to support the... Read More
The post Rejoni Raises $25 Million to Advance Juveena Hydrogel System Toward FDA Approval appeared first on citybiz.
Iovate Health Sciences International has appointed longtime executive and innovation leader Raza Bashir as Chief Executive Officer, signaling a renewed... Read More
The post Iovate Health Sciences Names Raza Bashir CEO to Lead Next Growth Phase appeared first on citybiz.
Eli Lilly and Company has acquired Austin-based biotechnology company 4E Therapeutics, adding a clinical-stage non-opioid pain program focused on chronic... Read More
The post Lilly Acquires 4E Therapeutics to Advance Non-Opioid Chronic Pain Pipeline appeared first on citybiz.
Komodo Health has named Miles Ennis President and elevated co-founder Web Sun to co-Chief Executive Officer, updating its leadership structure... Read More
The post Komodo Health Names Miles Ennis President in Executive Leadership Shift appeared first on citybiz.
GeneDx has named healthcare and genomics executive Mark Gardner as President, strengthening its leadership team as the company focuses on... Read More
The post GeneDx Appoints Mark Gardner as President to Support Growth in Genomic Medicine appeared first on citybiz.
Fellow Health Partners, a provider of revenue cycle management services for physician groups, ambulatory surgery centers and healthcare organizations across... Read More
The post Fellow Health Partners Secures Cleargate Capital Investment to Accelerate Growth appeared first on citybiz.
BioVie uses innovative approaches to try solving some of the most common and heartbreaking neurodegenerative health problems. President and CEO... Read More
The post BioVie Brings Better Hope for a World Without Debilitating and Heartbreaking Neurodegenerative Diseases appeared first on citybiz.
Immuneering Corporation has named biotechnology industry veteran Andrew Gengos as chief financial officer, adding an experienced public company executive as... Read More
The post Immuneering Appoints Former Terns Executive Andrew Gengos as CFO appeared first on citybiz.
Reunion Neuroscience has appointed biotechnology executive Sahil V. Kirpekar, M.D., as president, chief executive officer and a member of its... Read More
The post Reunion Neuroscience Names Sahil Kirpekar President and CEO appeared first on citybiz.
Vision Innovation Partners (VIP), a Mid-Atlantic ophthalmology platform with 69 locations, has appointed veteran retina specialist and healthcare executive Dr.... Read More
The post Vision Innovation Partners Names Dr. Brad Foster Chief Medical and Strategy Officer appeared first on citybiz.
AMN Healthcare has named Kristy Willis as chief commercial officer and Holly Novak as chief people officer, strengthening its executive... Read More
The post AMN Healthcare Appoints Kristy Willis and Holly Novak to Executive Leadership Team appeared first on citybiz.
Prime Radiant Partners has completed a $50 million growth equity investment in Cellares, marking the first investment for the healthcare-focused... Read More
The post Prime Radiant Makes Inaugural $50 Million Investment in Cellares’ Expanded Series D Round appeared first on citybiz.
CMI Media Group and Compas have announced a major expansion of their healthcare media and technology businesses, adding new capabilities... Read More
The post CMI Media Group and Compas Expand Healthcare Media, Data and AI Capabilities appeared first on citybiz.
A growing push to use biological data and artificial intelligence to identify disease risk earlier is driving new investment across... Read More
The post Nano Dimension Signs Term Sheet to Merge With Infinite Epigenetics in $890 Million Healthcare AI Deal appeared first on citybiz.
Los Angeles-based Remedy Science, a dermatologist-developed skincare brand, has announced the closing of its Series A funding round led by... Read More
The post Remedy Science Closes Series A Funding Led by L Catterton appeared first on citybiz.
Otsuka America, Inc., a subsidiary of Otsuka Pharmaceutical Co., Ltd., has completed its acquisition of Transcend Therapeutics, a clinical-stage biotechnology... Read More
The post Otsuka Completes $700M Acquisition of Transcend Therapeutics to Expand PTSD Pipeline appeared first on citybiz.
JAB Holding Company has completed its exit from Keurig Dr Pepper (NASDAQ: KDP), selling its remaining ownership stake in the... Read More
The post JAB Exits Keurig Dr Pepper Investment With Sale of Remaining 4.3% Stake appeared first on citybiz.
Vizient has acquired Empierus, a healthcare-focused advisory firm specializing in IT contracting, healthcare technology management and cost optimization, as the... Read More
The post Vizient Acquires Empierus to Expand Healthcare IT Spend Management Capabilities appeared first on citybiz.
Rocket Pharmaceuticals (NASDAQ: RCKT) has completed the sale of its Rare Pediatric Disease Priority Review Voucher (PRV) for $180 million,... Read More
The post Rocket Pharmaceuticals Completes $180 Million Sale of Priority Review Voucher appeared first on citybiz.
Adial Pharmaceuticals (NASDAQ: ADIL) announced the acquisition of Azora Therapeutics, a biotechnology company focused on inflammatory diseases, and a concurrent financing package of... Read More
The post Adial Pharmaceuticals Acquires Azora Therapeutics and Secures Up to $64 Million Financing appeared first on citybiz.
Rejuvenate Bio has closed a $6 million financing round and entered into a strategic research and development collaboration with Merck... Read More
The post Rejuvenate Bio Secures $6 Million Financing and Strategic Collaboration With Merck Animal Health appeared first on citybiz.
Positive Development has appointed healthcare industry veterans Dr. Alisa Bahl and Jon Pardew to its Board of Directors as the... Read More
The post Positive Development Adds Healthcare Veterans Alisa Bahl and Jon Pardew to Board appeared first on citybiz.
Methodist Healthcare Ministries of South Texas (MHM) has unveiled plans for Ministry Park, a large-scale mixed-use development in San Antonio’s... Read More
The post Methodist Healthcare Ministries Launches Ministry Park Development in South Texas Medical Center appeared first on citybiz.
Chiesi Group has completed its acquisition of KalVista Pharmaceuticals, strengthening its position in the rare disease market through the addition... Read More
The post Chiesi Completes Acquisition of KalVista, Expanding Rare Disease Portfolio with EKTERLY appeared first on citybiz.
New York-based Neion Bio has raised an oversubscribed $23 million in a Series A funding round led by Caffeinated Capital... Read More
The post Neion Bio Secures $23M to Scale Egg-Based Biologics Production Platform appeared first on citybiz.
VSee Health has completed the sale of its laboratory subsidiary, VSee Lab, in a strategic transaction that streamlines the company’s... Read More
The post VSee Health Divests Laboratory Unit, Retires 7% of Shares and Consolidates Leadership appeared first on citybiz.
Turbett Surgical has appointed Sean Bogle as Vice President of U.S. Sales, elevating a longtime company leader as the Rochester,... Read More
The post Turbett Surgical Names Sean Bogle Vice President of U.S. Sales appeared first on citybiz.
PharmaEssentia Corporation has acquired Canadian specialty pharmaceutical company FORUS Therapeutics in a transaction valued at $36.5 million, advancing the Taiwan-based... Read More
The post PharmaEssentia Acquires FORUS Therapeutics to Expand Canadian Commercial Operations appeared first on citybiz.
Merck Animal Health has agreed to acquire TARGAN, a Raleigh-based agricultural technology company specializing in automated biodevice solutions for the... Read More
The post Merck Animal Health Expands Poultry Technology Portfolio With TARGAN Acquisition appeared first on citybiz.
SOPHiA GENETICS (Nasdaq: SOPH) has confirmed a previously announced leadership transition that will see President Ross Muken become chief executive... Read More
The post Ross Muken to Become CEO as SOPHiA GENETICS Confirms Succession Plan Ahead of Annual Meeting appeared first on citybiz.
Cambridge, Mass.-based Ethyreal Bio has emerged from stealth with $101 million in financing, as investors back a new generation of... Read More
The post Ethyreal Bio Raises $101M as Investors Back New Approach to Graves’ and Thyroid Eye Disease appeared first on citybiz.
Fesarius Therapeutics has closed an oversubscribed $20 million Series A financing round to accelerate commercialization of its DermiSphere dermal regeneration... Read More
The post Fesarius Therapeutics Raises $20 Million Series A to Expand Commercial Adoption of DermiSphere appeared first on citybiz.
CervoMed has entered into a definitive securities purchase agreement for a private placement expected to generate approximately $10.5 million in... Read More
The post CervoMed Secures $10.5 Million Private Placement to Advance Neflamapimod Development appeared first on citybiz.
The U.S. Food and Drug Administration has cleared Imviva Biotech‘s Investigational New Drug application for CTA313, allowing the company to... Read More
The post FDA Grants IND Clearance for Imviva’s CTA313 Allogeneic CAR-T Therapy in Autoimmune Disease Treatment appeared first on citybiz.
Apollo Therapeutics has appointed Timothy P. Walbert, the former chairman, president and chief executive officer of Horizon Therapeutics, as chairman... Read More
The post Apollo Therapeutics Names Former Horizon CEO Timothy Walbert Chairman of the Board appeared first on citybiz.
BPGbio has appointed renowned neuroscientist Eric J. Nestler, M.D., Ph.D., as chair of its Scientific Advisory Board, a leadership transition... Read More
The post BPGbio Appoints Eric J. Nestler as Chair of Scientific Advisory Board, Succeeding Chas Bountra appeared first on citybiz.
The Guthrie Clinic has appointed Patricia “Pidge” Lohr, DNP, RN, CENP, as Chief Nurse Executive, effective June 22. In her... Read More
The post Guthrie Names Patricia “Pidge” Lohr Chief Nurse Executive appeared first on citybiz.
Quanterix Corporation (Nasdaq: QTRX) has appointed Jason Faessler as Chief Financial Officer, effective June 22, strengthening the company’s executive leadership... Read More
The post Quanterix Appoints Jason Faessler as Chief Financial Officer appeared first on citybiz.
The National Organization for Rare Disorders (NORD) has named Kathryn Lowell Executive Vice President of Government Affairs, adding a veteran... Read More
The post NORD Appoints Kathryn Lowell to Lead Government Affairs and Policy Strategy appeared first on citybiz.
Spring Fertility has appointed Haryanto “Hary” Hokianto as Chief Operating Officer and Mark Bokermann as Chief Financial Officer, adding two... Read More
The post Spring Fertility Names Hary Hokianto COO and Mark Bokermann CFO to Support National Growth appeared first on citybiz.
Vascarta Inc. has appointed healthcare industry veteran Richard Serbin as Chief Strategy Officer, adding an experienced pharmaceutical executive to its... Read More
The post Vascarta Appoints Former Johnson & Johnson Executive Richard Serbin as Chief Strategy Officer appeared first on citybiz.
Dana-Farber Cancer Institute announced it has received a historic $50 million grant from the Yawkey Foundation to support construction of... Read More
The post Dana-Farber Cancer Institute Receives Historic $50 Million Grant from Yawkey Foundation appeared first on citybiz.
Syntis Bio, a clinical-stage biopharmaceutical company developing oral therapeutics designed to leverage the small intestine, has appointed Matthew Dallas as... Read More
The post Syntis Bio Appoints Matthew Dallas as Chief Financial Officer appeared first on citybiz.
GT Medical Technologies has closed an oversubscribed $100 million Series E financing, securing capital to accelerate commercialization of its GammaTile... Read More
The post GT Medical Technologies Raises $100 Million Series E to Expand GammaTile Brain Tumor Treatment Platform appeared first on citybiz.
Novanta Inc. has agreed to acquire Riverpoint Medical from Arlington Capital Partners in a transaction valued at up to $1.45... Read More
The post Novanta to Acquire Riverpoint Medical from Arlington Capital Partners in $1.45 Billion Deal appeared first on citybiz.
As artificial intelligence expands into drug discovery, disease research and precision medicine, access to high-quality biological data is becoming a... Read More
The post Ambitious Bio Emerges From Stealth to Build Biological Data Infrastructure for AI appeared first on citybiz.
ZEO ScientifiX (OTCQB: ZEOX) has expanded its Medical Advisory Board with the appointment of nine physicians and scientific leaders specializing... Read More
The post ZEO ScientifiX Expands Medical Advisory Board With Regenerative Medicine and Longevity Experts appeared first on citybiz.
